Home Overview Committee ٰOrganizers Agenda Registration Sponsorship & Exhibition Venue & Hotel Contacts 简体中文版  
 
Agenda
 
China Biobanking Summit (VIP) 3rd Annual Biobank China 2013 Biobank Management

27th Sep.

Time Presentation Title Speaker
Main venue (Ballroom A-B-C) Chairman: Shengli Yang, Chingli Hu, Kurt Zatloukal, Bartha Maria Knoppers
09:00-09:30 Welcome Shengli Yang
 
S1: Translational Medicine & Biobank Chairman: Shengli Yang, Kurt Zatloukal
09:30-09:50 How Biobanks May Contribute to Innovation Kurt Zatloukal
09:50-10:10 The application of Biobanking in Clinic: Biomarkers for Kidney Disease Zhihong Liu
10:10-10:30 Biobankonomics: Developing a Sustainable Biospecimen Resource Jim Vaught
10:30-10:45 Tea Break & Group Photo
10:45-11:05 Rules of Biospecimen Resource Usage in China Yanrong Sun
11:05-11:25 Towards Global Sharing of Genomic and Clinical Data Bartha Maria Knoppers
11:25-11:45 Ethics Guideline for Shanghai Clinical Biobank Chingli Hu
11:45-12:00 Discussion
 
S2: Cohort studies for biobanks Chairman: Chingli Hu, Bartha Maria Knoppers
14:00-14:15 Shanghai Birth Cohort Study Jun Zhang
14:15-14:30 Cohort Study of Kodorrie Biobank Zhengming Chen
14:30-14:45 Exploration of Biobank Construction in Taiwan Chen-Yang Shen
14:45-15:00 Cohort Study in Columbia University Deliang Tang
15:00-15:15 Tea Break
15:15-15:30 Construction of National Cardiovascular Biobank Lixin Jiang
15:30-15:45 Gene & Environment: Prospective Cohort Study of Epidemics Xu Lin
15:45-16:00 Population-Based Cohort Study in Taizhou Xiaofeng Wang
16:00-16:15 Canada Child Birth Cohort Study William Fraser
16:15-16:30 Discussion

28th Sep.

>
Time Presentation Title Speaker
S3: Disease studies for biobanks Chairman: Jim Vaught, Jiayou Chu
09:00-09:15 Role of Government and Society in Biobanking Kan Zhang
09:15-09:30 The story of Beijing Biobank Peng Wang
09:30-09:45 Exploration of Major Disease-Based Biobank Development in Shanghai Peiyong Zheng
09:45-10:00 Implementing a State-of-the-Art Biorepository: The Genome Quebec-Chicoutimi Hospital Experience Steve Arsenault
10:00-10:15 Tea Break
10:15-10:30 Biobank & Data Base for Liver Cancer Weiping Zhou
10:30-10:45 Study of Susceptibility Genes: the Use of Rheumatism Bio-Samples Huji Xu
10:45-11:00 The Biobank of Neurology JinSong Wu
11:00-11:15 Cancer Biobank: Facility Management and Services Lianhai Zhang
11:15-11:30 Discussion
 
S4: Quality management systems for biobanking Chairman: Geogers Dagher, Yong Zhang
14:00-14:15 Proficiency Testing (PT) Project of ISBER & Biobank Andy Zaayange
14:15-14:30 Quality & Value in Biobanks Mark Divers
14:30-14:45 Toward the Establishment of Indicators for Evaluating Hospital-Integrated Tumor Biobanks: Main Current Stakes & Limitations Paul Holfman
14:45-15:00 Data Quality Control of Biobank Weiye Wang
15:00-15:15 Tea Break
15:15-15:30 Quality Perspectives in Biobanking Robert Jones
15:30-15:45 Quality Control of Nucleic Acid in Biobank Yong Zhang
15:45-16:00 Establishing a US Compliant Biorepository: Challenges & Successes Scott Clark
16:00-16:15 Data Management in UK Biobank James Brennan
16:15-16:30 Discussion
16:30-16:40 Closing Ceremony
 
 
Copyright 2013    Shanghai Clinical Research Center    All Rights Reserved